Variant report
Variant | esv3382574 |
---|---|
Chromosome Location | chr5:44929345-44931518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183665048 | chr5:44929437-44929438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528050257 | chr5:44929451-44929452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551093973 | chr5:44929495-44929496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564635084 | chr5:44929646-44929647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530553757 | chr5:44929663-44929664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550739106 | chr5:44929752-44929753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570249643 | chr5:44929799-44929800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567491323 | chr5:44929801-44929802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12109710 | chr5:44929928-44929929 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs547229535 | chr5:44929972-44929973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10941688 | chr5:44930005-44930006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539017980 | chr5:44930034-44930035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559030468 | chr5:44930053-44930054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536412645 | chr5:44930109-44930110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376866983 | chr5:44930134-44930135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575795503 | chr5:44930139-44930140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556265260 | chr5:44930191-44930192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574600248 | chr5:44930221-44930222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555124503 | chr5:44930230-44930231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10054773 | chr5:44930234-44930235 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs542468288 | chr5:44930320-44930321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189341655 | chr5:44930330-44930331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573102320 | chr5:44930343-44930344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544979660 | chr5:44930384-44930385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181287416 | chr5:44930442-44930443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530446054 | chr5:44930482-44930483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186340001 | chr5:44930530-44930531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111427086 | chr5:44930595-44930596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530265624 | chr5:44930606-44930607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151128896 | chr5:44930630-44930631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190176832 | chr5:44930641-44930642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34475196 | chr5:44930695-44930696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141414818 | chr5:44930706-44930707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10063172 | chr5:44930709-44930710 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs181532718 | chr5:44930767-44930768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145139338 | chr5:44930784-44930785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186548660 | chr5:44930836-44930837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555061037 | chr5:44930842-44930843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568465711 | chr5:44930941-44930942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191100573 | chr5:44930944-44930945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552933614 | chr5:44931024-44931025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs137884250 | chr5:44931042-44931043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544875953 | chr5:44931044-44931045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116014033 | chr5:44931071-44931072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10473376 | chr5:44931228-44931229 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs10473377 | chr5:44931246-44931247 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs561033152 | chr5:44931252-44931253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76321806 | chr5:44931263-44931264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531377443 | chr5:44931264-44931265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540802705 | chr5:44931353-44931354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:44929200-44929600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:44929600-44931400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr5:44931400-44931600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |